2023 Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Group Cellular Therapy & Immunobiology Working Party (CTIWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal J Immunother Cancer.
2023 Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases Group Autoimmune Diseases Working Party (ADWP) Infectious Diseases Working Party (IDWP) 1st listed author Raffaella Greco Journal J Autoimmun.
2023 Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry Group Infectious Diseases Working Party (IDWP) 1st listed author Per Ljungman Journal Front Immunol.
2023 Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) JACIE Working Party 1st listed author Riccardo Saccardi Journal Bone Marrow Transplant.
2023 Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) Haemoglobinopathies Working Party (HWP) Activity survey office COVID-19 1st listed author Jakob R Passweg Journal Bone Marrow Transplant.
2023 Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study Group Infectious Diseases Working Party (IDWP) Other society 1st listed author Dina Averbuch Journal Bone Marrow Transplant.
2023 Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey Group Infectious Diseases Working Party (IDWP) 1st listed author Moshe Yeshurun Journal Bone Marrow Transplant.
2022 Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia Group Infectious Diseases Working Party (IDWP) 1st listed author Anne Bergeron Journal Lancet Infect Dis.
2022 Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Transpl Infect Dis.
2022 New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectiois Diseases Working Pary of EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Simone Cesaro Journal Bone Marrow Transplant.
2022 Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) Group Infectious Diseases Working Party (IDWP) Other society 1st listed author Georg Maschmeyer Journal Leukemia.
2022 Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9) Group Infectious Diseases Working Party (IDWP) Other society COVID-19 1st listed author Simone Cesaro Journal Leukemia.